Epithelial neutrophil localization and tight junction Claudin‐2 expression are innovative outcome predictors in inflammatory bowel disease
Authors:
Open Access
- 3 October 2024
- journal article
- research article
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (9) , 1155-1166
Abstract
Background: Patients with inflammatory bowel disease (IBD) in clinical and endoscopic remission may still experience disease relapse. Therefore, there is a need to identify outcome predictors. Recently, the role of neutrophils in predicting outcomes in ulcerative colitis (UC) has been highlighted. Furthermore, the impairment of intestinal barrier plays a key role in forecasting disease outcomes in IBD.Objective: This observational study aimed to assess the predictive role of neutrophils according to tissue localization and intestinal barrier protein expression in IBD.Methods: IBD patients in clinical remission who underwent colonoscopy between January 2020 and June 2022 at two tertiary referral centres were enrolled. Patients with Mayo Endoscopic Score ≤1 (UC) and Simple Endoscopic Score ≤6 (Crohn's disease) were included. Histological activity was assessed using validated scores. Experienced pathologists evaluated neutrophil localization in the epithelium and lamina propria and immunohistochemical expression of Claudin‐2 and junctional adhesion molecule A (JAM‐A).Results: Of 60 UC and 76 CD patients, 59.7% had histological activity. 25.8% of patients developed an adverse outcome within 12 months. Neutrophils in the epithelium predicted adverse outcomes for UC (hazard ratio [HR] 5.198, p = 0.01) and CD (HR 4.377, p = 0.03) patients in endoscopic remission. Claudin‐2 expression correlated with endoscopic and histological activity and predicted outcomes in UC. Similar results were found for JAM‐A in CD despite this protein showing less specificity as a barrier predictor of outcome.Conclusion: This study highlights the potential role of epithelial neutrophil localization and Claudin‐2 ‘leaky gut’ expression as tools for predicting IBD outcomes and guiding further patient‐tailored therapy.Keywords
This publication has 36 references indexed in Scilit:
- Mucosal barrier dysfunction and relapse in ulcerative colitis: Is there more that meets the eye?Digestive and Liver Disease, 2024
- The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal RepairGastroenterology, 2021
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology, 2021
- Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 ExpressionGastroenterology, 2019
- Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin EGastroenterology, 2019
- Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiativeJournal of Crohn's and Colitis, 2014
- Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformationLaboratory Investigation, 2008
- Unique Role of Junctional Adhesion Molecule-A in Maintaining Mucosal Homeostasis in Inflammatory Bowel DiseaseGastroenterology, 2008
- Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort StudyGastroenterology, 2007
- Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitisGastroenterology, 2004